Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
3/7/2023
/ Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Electronic Prescribing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
HRSA ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Telehealth ,
Telemedicine
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
12/26/2022
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Hospitals ,
Medical Devices ,
Medicare ,
Medicare Part B ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Popular ,
SAMHSA ,
Telehealth
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
6/20/2022
/ Centers for Disease Control and Prevention (CDC) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
National Institute of Health (NIH) ,
OIG ,
Provider Relief Fund ,
Telehealth ,
Telemedicine
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
5/9/2022
/ Centers for Disease Control and Prevention (CDC) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Investigational New Drug Application (IND) ,
Medicaid ,
Medical Devices ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Telehealth ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more